MeVis Medical Solutions AG (ETR:M3V)

ETR:M3V Statistics

Total Valuation

ETR:M3V has a market cap or net worth of EUR 42.22 million. The enterprise value is 38.57 million.

Market Cap	42.22M
Enterprise Value	38.57M

Important Dates

The last earnings date was Thursday, May 21, 2026.

Earnings Date	May 21, 2026
Ex-Dividend Date	Mar 20, 2026

Share Statistics

ETR:M3V has 1.82 million shares outstanding.

Current Share Class	1.82M
Shares Outstanding	1.82M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	21.70%
Float	479,388

Valuation Ratios

The trailing PE ratio is 30.50.

PE Ratio	30.50
Forward PE	n/a
PS Ratio	2.73
PB Ratio	2.37
P/TBV Ratio	2.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	27.86
EV / Sales	2.49
EV / EBITDA	48.12
EV / EBIT	59.56
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.16

Current Ratio	3.16
Quick Ratio	3.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	47.17

Financial Efficiency

Return on equity (ROE) is 7.77% and return on invested capital (ROIC) is 4.14%.

Return on Equity (ROE)	7.77%
Return on Assets (ROA)	1.73%
Return on Invested Capital (ROIC)	4.14%
Return on Capital Employed (ROCE)	3.06%
Weighted Average Cost of Capital (WACC)	4.08%
Revenue Per Employee	138,249
Profits Per Employee	12,361
Employee Count	112
Asset Turnover	0.66
Inventory Turnover	n/a

Taxes

In the past 12 months, ETR:M3V has paid 95,140 in taxes.

Income Tax	95,140
Effective Tax Rate	6.43%

Stock Price Statistics

The stock price has decreased by -7.94% in the last 52 weeks. The beta is -0.03, so ETR:M3V's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-7.94%
50-Day Moving Average	23.19
200-Day Moving Average	24.59
Relative Strength Index (RSI)	46.62
Average Volume (20 Days)	31

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ETR:M3V had revenue of EUR 15.48 million and earned 1.38 million in profits. Earnings per share was 0.76.

Revenue	15.48M
Gross Profit	3.13M
Operating Income	647,652
Pretax Income	1.48M
Net Income	1.38M
EBITDA	801,628
EBIT	647,652
Earnings Per Share (EPS)	0.76

Balance Sheet

The company has 3.65 million in cash and n/a in debt, with a net cash position of 3.65 million or 2.01 per share.

Cash & Cash Equivalents	3.65M
Total Debt	n/a
Net Cash	3.65M
Net Cash Per Share	2.01
Equity (Book Value)	17.83M
Book Value Per Share	9.79
Working Capital	4.37M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	153,976
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 20.24%, with operating and profit margins of 4.18% and 8.94%.

Gross Margin	20.24%
Operating Margin	4.18%
Pretax Margin	9.56%
Profit Margin	8.94%
EBITDA Margin	5.18%
EBIT Margin	4.18%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.13, which amounts to a dividend yield of 4.87%.

Dividend Per Share	1.13
Dividend Yield	4.87%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	4.83%
Earnings Yield	3.28%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ETR:M3V has an Altman Z-Score of 6.39 and a Piotroski F-Score of 3.

Altman Z-Score	6.39
Piotroski F-Score	3